Dolby Laboratories (DLB) Tops Q2 EPS by 8c; Offers Strong Q3 EPS Guidance

Go back to Dolby Laboratories (DLB) Tops Q2 EPS by 8c; Offers Strong Q3 EPS Guidance

JPMorgan Upgrades Dolby Laboratories (DLB) to Overweight

April 22, 2015 6:45 AM EDT

JPMorgan upgraded Dolby Laboratories (NYSE: DLB) from Neutral to Overweight with a price target of $48.00 (from $39.00). Yesterday Dolby Laboratories reported Q2 earnings results.

For an analyst ratings summary and ratings history on Dolby Laboratories... More